Chronic Myeloid Leukemia (CML)

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myeloid Leukemia (CML) Trial in France

Recruiting
  • Chronic Myeloid Leukemia (CML)
    • Annecy, France
    • +11 more
    Jul 18, 2023

    Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

    Completed
    • Chronic Myeloid Leukemia (CML)
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

    Active, not recruiting
    • Acute Lymphoid Leukemia (ALL)
    • +5 more
    • Hyperfractionated total body irradiation
    • +9 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 21, 2022

    Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • +7 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 8, 2021

    Chronic Myeloid Leukemia (CML) Trial in Nanjing ([14C] HQP1351)

    Completed
    • Chronic Myeloid Leukemia (CML)
    • [14C] HQP1351
    • Nanjing, China
      The First Affiliated Hospital with Nanjing Medical University
    Sep 7, 2021

    Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

    Completed
    • Myelodysplastic Syndrome (MDS)
    • +2 more
    • WT1:126-134
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 15, 2021

    Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

    Not yet recruiting
    • Chronic Myeloid Leukemia (CML)
    • Ponatinib 15mg QD
    • Ponatinib 30mg QD
    • Cagliari, Italy
    • +12 more
    Jan 31, 2021

    Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

    Recruiting
    • Chronic Myeloid Leukemia (CML)
    • +5 more
    • CliniMACS CD34+ Reagent System
    • +8 more
    • New York, New York
      Columbia University Medical Center
    Jun 17, 2020

    EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia

    Unknown status
    • Chronic Myeloid Leukemia (CML)
    • Chronic Phase
    • Collection of blood and bone marrow
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Oct 8, 2018

    Chronic Myeloid Leukemia (CML) Trial in France (Pioglitazone + TKI)

    Unknown status
    • Chronic Myeloid Leukemia (CML)
    • Pioglitazone + TKI
    • Le Chesnay, France
    • +3 more
    Mar 20, 2018

    Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Trial in United States

    Approved for marketing
    • Chronic Myeloid Leukemia (CML)
    • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
    • La Jolla, California
    • +32 more
    Feb 5, 2018

    Chronic Myeloid Leukemia (CML) Trial in Brazil (AMN107)

    Withdrawn
    • Chronic Myeloid Leukemia (CML)
    • Fortaleza, CE, Brazil
    • +17 more
    Apr 19, 2017

    Chronic Myeloid Leukemia (CML) Trial in Seoul (Imatinib/Acetaminophen)

    Completed
    • Chronic Myeloid Leukemia (CML)
    • Seoul, Korea, Republic of
      Novartis Investigative Site
    Apr 20, 2016

    Patients Receiving Tyrosine Kinase Inhibitor Therapy With

    Completed
    • Chronic Myeloid Leukemia (CML)
    • (no location specified)
    Apr 5, 2016

    Healthcare Costs Among CML Receiving Dasatinib or Nilotinib

    Completed
    • Chronic Myeloid Leukemia (CML)
      • Clinton, South Carolina
        Franklin Pharmaceutical Consulting, Llc
      Jul 3, 2015

      Myelodysplastic Syndrome, Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI (WT1 Peptide

      Completed
      • Myelodysplastic Syndrome
      • +2 more
      • WT1 Peptide Vaccine
      • Bethesda, Maryland
        National Cancer Institute (NCI), 9000 Rockville Pike
      Jun 5, 2014

      Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Other Glivec/Gleevec

      Terminated
      • Chronic Myeloid Leukemia (CML)
      • +2 more
      • Moscow, Russian Federation
        Novartis Investigative Site
      Mar 12, 2012